Abstract
Osteoporosis is a significant health and economic issue, as it predisposes patients to a higher risk of bone fracture. Measuring bone mineral density has been shown to be an accurate way to assess the risk for osteoporosis. The most common way for bone density testing is a dual-energy X-ray absorptiometry (DEXA) scan, which may be recommended for patients with increased risk of osteoporosis. Radiograph imaging is widely available in clinical settings and acquired for many reasons, such as trauma or pain. The goal of this project is to extract radiomics information from pelvic X-rays (both the hip and femoral neck regions) to assess the risk of osteoporosis (triaging patients into “normal” vs. “at-risk”, or “low risk” vs. “high risk” categories). The motivation here is not to replace the DEXA scan but to proactively identify patients at risk for osteoporosis and appropriately refer them to management options. We apply machine learning-based radiomics techniques on a study cohort of 565 patients. Our preliminary results show that a correlation between the radiomics features extracted from pelvic X-rays and the level of osteoporosis risk derived from the DEXA test results.
Competing Interest Statement
Shandong Wu is a scientific consultant and stockholder of COGNISTX, Inc for work unrelated to this study. Shandong Wu receives research grants from the National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Science Foundation, Radiological Society of North America, UPMC Hillman Cancer Center, and Amazon.
Funding Statement
This work was supported in part by the Pilot Research Program of the Pittsburgh Center for AI Innovation in Medical Imaging and the associated Pitt Momentum Funds of a Scaling grant from the University of Pittsburgh (2020) and by an Amazon Machine Learning Research Award.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of the University of Pittsburgh gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The imaging and patient data in the present study are not available due to privacy considerations. The result data are available upon reasonable request to the authors.
